Why Finasteride Feels "Slow" in Month One (and Why That's Normal)
Affiliate disclosure: This page contains affiliate links. We may earn a commission at no extra cost to you. Editorial content is independent.
Month one of finasteride is biological groundwork, not visible progress. The absence of results in the first four weeks is not a sign that anything is wrong.
The most common message sent to telehealth providers in the first weeks of finasteride is some version of: “I don't think it's working. I don't see any difference.” It is understandable. You started a medication for a visible condition; you are looking for a visible result; there is none. What is actually happening requires separating the pharmacological timeline from the biological timeline.
What the pharmacological timeline looks like
Finasteride reaches its pharmacological effect quickly. The drug begins inhibiting 5-alpha-reductase type 2 — the enzyme responsible for converting testosterone to DHT — within hours of the first dose. By approximately one to two weeks of daily 1mg dosing, blood DHT levels have dropped to their steady-state suppressed level, around 70% below baseline for serum DHT. Scalp DHT, which is the relevant measure for androgenetic alopecia, reaches approximately 60–70% suppression.
At the two-week point, the medication has done its pharmacological job. DHT suppression is established. This is not visible in the mirror because DHT suppression is not the same as hair growth. It is the prerequisite for hair growth to resume — the removal of the signal that was shortening the follicle growth cycle — but it is not itself growth.
What the biological timeline looks like
The hair follicle cycle operates on a timescale measured in months. The growth phase (anagen) for scalp hair lasts two to six years under normal conditions and is compressed in androgenetic alopecia. The transition phase (catagen) lasts two to three weeks. The resting and shedding phase (telogen) lasts two to four months.
When DHT suppression is established, follicles that were in the compressed, miniaturising cycle are gradually released. But “gradually” means on the hair follicle timescale, not the pharmacological timescale. The follicle has to transition through whatever phase it was in, go through telogen, shed the current hair, and then begin a new, healthier anagen cycle. That process takes months.
Month one is almost entirely in the zone between pharmacological onset and any biological response. The drug is working. The hair cycle has not had time to respond yet.
Why the absence of change can feel like failure
The expectation mismatch is partly structural. Hair growth products — across pharmaceutical, supplement, and cosmetic categories — are marketed with before-and-after photographs that imply significant visible change. Those photographs represent exceptional responders at twelve months, not typical users at one month. The one-month expectation, fed by marketing rather than pharmacological reality, creates a gap that does not reflect anything about how the medication is actually performing.
The other factor is the dread shed. If shedding is increasing in month one, the visible evidence points in the wrong direction. This is one of the more important things to know before starting: early increased shedding is not failure, and the instinct to conclude that it is failure from the available evidence is understandable and incorrect.
What to track in month one instead
Rather than looking for visible hair change (which is not expected), the useful things to track in month one are:
- Shedding rate. Take note of your approximate daily shed count or the density in the shower drain. This is the baseline for comparison in months two through four, when shedding should reduce.
- Side effect presence or absence. The first few weeks are when any side effects will typically first appear if they are going to. Most people experience none; the ones that occur early are worth noting and discussing with your prescribing clinician if they persist.
- Consistency of dosing. Finasteride requires daily dosing to maintain DHT suppression. Month one is the habit-formation period. Building the daily dose into a consistent routine now (morning with breakfast, evening before bed — whatever is most consistent) matters more than anything you could observe in a mirror.
When does month one actually end?
Not at the four-week point, in terms of what to look for. The first useful observation window is months two to four, when shedding changes become noticeable. The first meaningful result assessment is at six months. The first fair and complete assessment is at twelve months.
Month one is the beginning of a twelve-month biological process. Its clinical job is to establish the DHT suppression that makes the rest of the process possible. It does that job invisibly and completely. The absence of a visible result at four weeks is not a signal. It is month one being month one.
Common questions
Should I see any results in the first month of finasteride?
No visible hair results are expected in the first month. The medication reaches its pharmacological effect quickly (steady-state DHT suppression within two weeks), but the hair follicle cycle does not respond on a four-week timescale. The first measurable signal — reduced shedding — typically appears between months two and four.
What is actually happening in month one if I can't see any change?
Finasteride is suppressing DHT at the scalp. Follicles that have been miniaturising in a compressed, DHT-driven cycle are beginning to be released from that suppression. The cycle is being reset at the follicular level. This process takes weeks to produce any externally visible effect because the hair growth cycle operates on a month-to-month timescale, not week-to-week.
What if shedding increases in month one?
That is also normal and expected by many users. The dread shed — temporary increased shedding as the follicle cycle resets — can begin as early as weeks four to six. If shedding is increasing in month one, the medication is likely active and the cycle is being reset. Continue unless you are experiencing side effects that warrant clinical discussion.
References & further reading
- Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia. Dermatologic Clinics, 1996.
- Olsen EA, et al. The importance of dual 5-alpha reductase inhibition in the treatment of male pattern hair loss. Journal of the American Academy of Dermatology, 2006.
Get your prescription
Care Bare Rx
Telehealth hair loss evaluation with licensed clinicians. Online intake, same-week prescriptions, and compounded finasteride or combination formulas shipped directly to your door.
Start Your Care Bare Rx Intake Paid linkSesame Care
Book directly with licensed physicians at transparent, upfront prices. FDA-approved brand-name and generic finasteride prescriptions, no insurance required, no membership fee.
Browse Sesame Care Providers Paid linkAbout compounded medications: Compounded drugs are prepared by a pharmacy for an individual patient and are not FDA-approved. The FDA does not review them for safety, effectiveness, or manufacturing quality. Discuss the trade-offs with a licensed prescriber before starting.
Affiliate Disclosure: This site earns commissions on referrals. Editorial content is independent. We only feature licensed, verified providers.
Medical disclaimer: This article is for general information only and does not constitute medical advice, diagnosis, or treatment. Finasteride is a prescription medication with a documented side effect profile. Always consult a licensed physician before starting, stopping, or changing any medication.